RespireRx Pharmaceuticals Inc. (OTCPK:RSPI) announced that it has equity purchase agreement for a private placement of common shares for gross proceeds of $2,000,00 on July 28, 2020. the company also issued a convertible 8% fixed promissory note for gross proceeds of $25,000. The transaction will include participation from White Lion Capital, LLC. The notes will bear a fixed interest rate of 8% and will mature on July 28, 2021. The notes will be convertible into common shares of the company at a price of $0.02 per share. On the same day, the company received $25,000 in its first tranche from issuance of convertible notes.